Metabolic adverse events associated with systemic corticosteroid therapy—a systematic review and meta-analysis

OBJECTIVES: To assess the risk of new-onset or worsening hyperglycaemia, hypertension, weight gain and hyperlipidaemia with systemic corticosteroid therapy (CST) as reported in published randomised control trial (RCT) studies. DATA SOURCES: Literature search using MEDLINE, EMBASE, Cochrane library,...

Descripción completa

Detalles Bibliográficos
Autores principales: Kulkarni, Spoorthy, Durham, Hannah, Glover, Luke, Ather, Osaid, Phillips, Veronica, Nemes, Szilard, Cousens, Leslie, Blomgran, Parmis, Ambery, Philip
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Pharmacology and Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9772659/
https://www.ncbi.nlm.nih.gov/pubmed/36549729
http://dx.doi.org/10.1136/bmjopen-2022-061476

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9772659/
https://www.ncbi.nlm.nih.gov/pubmed/36549729
http://dx.doi.org/10.1136/bmjopen-2022-061476

Ejemplares similares